Journals / Türk Kardiyoloji Derneği Arşivi / 2018 / Cilt: 46 - Sayı: 3

Disseminated adenovirus infection in heart and kidney transplant

Kalp-böbrek alıcısında yaygın adenovirüs enfeksiyonu

Pages
231–233
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Early diagnosis and treatment are criticalto improving outcomes in immunocompromised patients

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Presently described is a case of disseminatedadenovirus infection in a heart-kidney transplant recipientthat was successfully treated with cidofovir.
📊
Key Findings & Data:There areseveral reports of adenovirus infections in adult solid organtransplant recipients and the prognosis is usually poor, withmortality rates of 40% to 60%.
💡
Conclusion & Impact:Early diagnosis and treatment are criticalto improving outcomes in immunocompromised patients
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Presently described is a case of disseminatedadenovirus infection in a heart-kidney transplant recipientthat was successfully treated with cidofovir. There areseveral reports of adenovirus infections in adult solid organtransplant recipients and the prognosis is usually poor, withmortality rates of 40% to 60%. Severe disseminated adenovirusinfections have been associated with increased riskof adverse transplant events, such as rejection, ventriculardysfunction, allograft vasculopathy, graft loss, and the needfor re-transplantation. The patient’s lack of clinical improvement,the onset of hemorrhagic cystitis and acute kidney injurywere factors in our decision to temporarily discontinueadministration of immunosuppressive agents and start anantiviral agent. It is important to suspect adenovirus in transplantpatients when they do not respond to antibiotics andcultures are negative. Early diagnosis and treatment are criticalto improving outcomes in immunocompromised patients

Özet

Burada sidofovir ile başarıyla tedavi edilen bir kalpböbrek alıcısında yaygın adenovirüs enfeksiyonu olgusunu tanımlıyoruz. Erişkin solid organ transplant alıcılarında prognozu genellikle kötü, ölüm oranları %40–60 arası birkaç adenovirüs enfeksiyonu olgusu bildirilmiştir. Ağır yaygın adenovirüs enfeksiyonları organ rejeksiyon, ventrikül işlev bozukluğu allogreft vaskülopatisi, greft kaybı ve yeniden transplantasyon gerekliliği gibi giderek artan olumsuz transplant olayları riskiyle ilişkilendirilmiştir. Hastada klinik iyileşmemenin olmaması, hemorajik sistit başlangıcı ve akut böbrek hasarı geçici olarak bağışıklık sistemini baskılayıcı ilaçların uygulanmasını durdurup bir antiviral ilaca başlama kararımıza etkili faktörler olmuştur. Antibiyotiklere yanıt vermedikleri ve kültürlerin negatif olduğu durumlarda transplant hastalarında adenovirüsten kuşkulanılması önemlidir. Bağışıklık sistemi risk altında olan hastalarda sonuçları iyileştirmede erken tanı ve tedavi önem taşır

🔖

Cite This Article

Xu, J., Patel, K. V., Dsouza, M., Almendral, J., Mody, K., Iyer, D. (2022). Disseminated adenovirus infection in heart and kidney transplant. Türk Kardiyoloji Derneği Arşivi, Cilt: 46 - Sayı: 3, 231–233. https://ajindex.com/articles/632123

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Humar A, Kumar D, Mazzulli T, Razonable RR, Moussa G, Paya CV, et al. A surveillance study of adenovirus infection in adult solid organ transplant recipients. Am J Transplant 2005;5:2555–9
  2. Ivan D, Frazier OH, Abrams J. Fatal disseminated adenoviral infection in an adult heart transplant patient. J Heart Lung Transplant 2004;23:1209–12
  3. Florescu DF, Kwon JY, Dumitru I. Adenovirus infections in heart transplantation. Cardiol Rev 2013;21:203–6
  4. Duggan JM, Farrehi J, Duderstadt S, Turner NJ, Fekety R. Treatment with ganciclovir of adenovirus pneumonia in a cardiac transplant patient. Am J Med 1997;103:439–40
  5. Refaat M, McNamara D, Teuteberg J, Kormos R, McCurry K, Shullo M, et al. Successful cidofovir treatment in an adult heart transplant recipient with severe adenovirus pneumonia. J Heart Lung Transplant 2008;27:699–700
  6. Gupta A, Philip A, Ranga K, Cappa J, Dougherty J, Lawlor M. An interesting case of adenoviral hepatitis in a cardiac transplant recipient. Transpl Infect Dis 2010;12:84–6
  7. Yusen RD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Goldfarb SB, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Lung and Heart-Lung Transplantation Report- 2015; Focus Theme: Early Graft Failure. J Heart Lung Transplant 2015;34:1264–77
  8. Mehta V, Chou PC, Picken MM. Adenovirus disease in six small bowel, kidney and heart transplant recipients; pathology and clinical outcome. Virchows Arch 2015;467:603–8
  9. Donoso Mantke O, Meyer R, Prösch S, Nitsche A, Leitmeyer K, Kallies R, et al. High prevalence of cardiotropic viruses in myocardial tissue from explanted hearts of heart transplant recipients and heart donors: a 3-year retrospective study from a German patients’ pool. J Heart Lung Transplant 2005;24:1632–8.